The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 10,501–10,600 of 31,469
Noguchi, H., Yamada, Y., Okitsu, T., Iwanaga, Y., Nagata, H., Kobayashi, N., Hayashi, S., & Matsumoto, S. (2008) · Cell Transplantation · doi:10.3727/000000008783906991 · Cited by 34
Beneficial Effects of an 8-Week, Very Low Carbohydrate Diet Intervention on Obese Subjects
Gu, Y., Yu, H., Li, Y., Ma, X., Lu, J., Yu, W., Xiao, Y., Bao, Y., & Jia, W. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/760804 · Cited by 34
Sivakumar, K., Bari, M. F., Adaikalakoteswari, A., Guller, S. M., Weickert, M. O., Randeva, H. S., Grammatopoulos, D. K., Bastie, C. C., & Vatish, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4293 · Cited by 34
Bala, M., Martin, J., Kopp, A., Hanses, F., Buechler, C., & Schäffler, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0342 · Cited by 34
Celik, C., Baştu, E., Abalı, R., et al. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.774361 · Cited by 34
Polymorphisms in KCNQ1 Are Associated with Gestational Diabetes in a Korean Population
Kwak, S. H., Kim, T. H., Cho, Y. M., Choi, S. H., Jang, H. C., & Park, K. S. (2010) · Hormone Research in Paediatrics · doi:10.1159/000313918 · Cited by 33
Décordé, K., Agne, A., Lacan, D., Ramos, J., Fouret, G., Ventura, E., Feillet‐Coudray, C., Cristol, J., & Rouanet, J. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf900504g · Cited by 34
High Energy Diets-Induced Metabolic and Prediabetic Painful Polyneuropathy in Rats
Xie, F., Han, F., Hou, J., Jiao, K., Costigan, M., & Chen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057427 · Cited by 35
Rask, E., Šimonytė, K., Lönn, L., & Axelson, M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04333.x · Cited by 38
Araki, T., Emoto, M., Konishi, T., Ikuno, Y., Lee, E., Teramura, M., Motoyama, K., Yokoyama, H., Mori, K., Koyama, H., et al. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.006 · Cited by 34
Usinger, L., Hansen, K. B., Kristiansen, V. B., Larsen, S., Holst, J. J., & Knop, F. K. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0362-9 · Cited by 33
Tambascia, M. A., Geloneze, B., Repetto, E. M., Geloneze, S. R., Picolo, M., & Magro, D. O. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00285.x · Cited by 34
Faintuch, J., Bortolotto, L. A., Marques, P. C. D. O. C., Faintuch, J., França, J. Í. D., & Cecconello, I. (2011) · PubMed · Cited by 35
Siahanidou, T., Garatzioti, M., Lazaropoulou, C., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0476 · Cited by 34
Huyen, V. T. T., Phan, D. V., Thang, P., et al. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/452313 · Cited by 34
Serum peptide YY in response to short-term overfeeding in young men
Cahill, F., Shea, J. L., Randell, E. W., Vasdev, S., & Sun, G. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.003624 · Cited by 37
Impaired Glucose-Induced Glucagon Suppression after Partial Pancreatectomy
Schrader, H., Menge, B. A., Breuer, T. G. K., Ritter, P. R., Uhl, W. H., Schmidt, W. E., Holst, J. J., & Meier, J. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0826 · Cited by 36
Safar, F. H., Mojiminiyi, O. A., Al‐Rumaih, H., & Diejomaoh, M. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.152025 · Cited by 34
Ziaee, A., Esmailzadehha, N., Oveisi, S., Ghorbani, A., & Ghanei, L. (2015) · PubMed · Cited by 34
d3‐Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype
Montefusco, L. B., Filopanti, M., Ronchi, C. L., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03703.x · Cited by 34
Increased Arterial Stiffness in Normoglycemic Normotensive Offspring of Type 2 Diabetic Parents
Giannattasio, C., Failla, M., Capra, A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.097535 · Cited by 34
Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children
Kłusek-Oksiuta, M., Białokoz‐Kalinowska, I., Tarasów, E., Wojtkowska, M., Werpachowska, I., & Lebensztejn, D. M. (2014) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-014-0084-4 · Cited by 34
Tsai, Y.-H., Wang, T.-W., Wei, H.-J., Hsu, C.-Y., Ho, H.-J., Chen, W.-H., Young, R., Liaw, C.-M., & Chao, J. C.-J. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512004369 · Cited by 34
Baoying, H., Chen, H., Qiu, C., Wu, P., Qingfei, L., Lin, Y., Huang, H., Jixing, L., Li, L., Chen, L., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004419 · Cited by 34
der Schueren, B. V., Homel, P., Alam, M., Agenor, K., Wang, G., Reilly, D., & Laferrère, B. (2011) · Diabetes Care · doi:10.2337/dc11-1472 · Cited by 34
Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives
Sanchez, R. A., Masnatta, L. D., Pesiney, C., Fischer, P., & Ramirez, A. J. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328312677e · Cited by 34
Expression of adrenomedullin in adipose tissue of lean and obese women
Paulmyer‐Lacroix, O., Desbrière, R., Poggi, M., Achard, V., Alessi, M., Boudouresque, F., Ouafik, L., Vuaroqueaux, V., Labuhn, M., Dutourand, A., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02170 · Cited by 34
Pοlyzos, S. A., Kountouras, J., Παπαθεοδώρου, Α., et al. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31316-x · Cited by 34
Finken, M. J. J., Meulenbelt, I., Dekker, F. W., Frölich, M., Romijn, J. A., Slagboom, P. E., & Wit, J. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1290 · Cited by 34
Tan, J. T., Tan, L. S. M., Chia, K. S., Chew, S. K., & Tai, E. S. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.08.005 · Cited by 35
Zinc ions in the endocrine and exocrine pancreas of zinc deficient rats.
Søndergaard, L. G., Stoltenberg, M., Doering, P., et al. (2006) · PubMed · doi:10.14670/hh-21.619 · Cited by 34
Pancreatic β‐cell failure in obese mice with human‐like CMP‐Neu5Ac hydroxylase deficiency
Kavaler, S. T., Morinaga, H., Jih, A., Fan, W., Hedlund, M., Varki, A. P., & Kim, J. J. (2011) · The FASEB Journal · doi:10.1096/fj.10-175281 · Cited by 34
A Central Role of RLIP76 in Regulation of Glycemic Control
Awasthi, S., Singhal, S. S., Yadav, S., Singhal, J., Vatsyayan, R., Zając, E., Luchowski, R., Borvak, J., Gryczynski, K., & Awasthi, S. (2009) · Diabetes · doi:10.2337/db09-0911 · Cited by 35
Hwangbo, Y., Kim, J. T., Kim, E. K., et al. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.2.136 · Cited by 34
Adipocyte Triglyceride Turnover Is Independently Associated With Atherogenic Dyslipidemia
Frayn, K. N., Bernard, S., Spalding, K. L., & Arner, P. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003467 · Cited by 36
Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments
Ronchi, C. L., Giavoli, C., Ferrante, E., Verrua, E., Bergamaschi, S., Ferrari, D., Corbetta, S., Montefusco, L. B., Arosio, M., Ambrosi, B., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0222 · Cited by 34
Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population
Esteghamati, A., Zandieh, A., Khalilzadeh, O., Meysamie, A., & Ashraf, H. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-36 · Cited by 35
Polak, J., Kovacova, Z., Holst, J. J., Verdich, C., Astrup, A. V., Blaak, E. E., Patel, K., Oppert, J., Langin, D., Martínez, J. A., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0512 · Cited by 34
Goletzke, J., Herder, C., Joslowski, G., Bolzenius, K., Remer, T., Wudy, S. A., Roden, M., Rathmann, W., & Buyken, A. E. (2013) · Diabetes Care · doi:10.2337/dc12-2063 · Cited by 34
Al‐Daghri, N. M., Al‐Rubean, K., Bartlett, W. A., Al‐Attas, O., Jones, A. F., & Kumar, S. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01044.x · Cited by 34
Demirci, H., Yılmaz, M., Ergün, M. A., Yurtçu, E., Bukan, N. C., & Ayvaz, G. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903367051 · Cited by 34
Yadav, R. K., Khadgawat, R., Sarvottam, K., Yadav, R., & Netam, R. K. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.160698 · Cited by 35
Wang, X., Smith, G. I., Patterson, B. W., Reeds, D. N., Kampelman, J., Magkos, F., & Mittendorfer, B. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00533.2011 · Cited by 34
Lin, H., Huang, Y., Shiue, H.-S., et al. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.08.018 · Cited by 34
Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients
Wang, J., Bao, Y., Hu, C., Zhang, R., Wang, C., Lu, J., Jia, W., & Xiang, K. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00744.x · Cited by 34
Kim, J., Bhattacharjee, R., Gozal, D., Khalyfa, A., Capdevila, Ó. S., Tauman, R., & Gozal, D. (2010) · International Journal of Pediatrics · doi:10.1155/2010/846098 · Cited by 34
Teeuwisse, W. M., Widya, R. L., Paulides, M., Lamb, H. J., Smit, J. W. A., Roos, A., van Buchem, M. A., Pijl, H., & van der Grond, J. (2012) · Diabetes · doi:10.2337/db11-1835 · Cited by 33
Mehanna, E. T., Mesbah, N. M., Ghattas, M. H., Saleh, S. M., & Abo–Elmatty, D. M. (2015) · Endocrine Research · doi:10.3109/07435800.2015.1066802 · Cited by 34
Dreber, H., Reynisdottir, S., Angelin, B., & Hemmingsson, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145273 · Cited by 35
Ferron, A. J. T., Jacobsen, B. B., Sant’Ana, P. G., de Campos, D. H. S., de Tomasi, L. C., Luvizotto, R. D. A. M., Cicogna, A. C., Leopoldo, A. S., & Lima‐Leopoldo, A. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138605 · Cited by 34
Ghorbanzadeh, V., Mohammadi, M., Dariushnejad, H., Chodari, L., & Mohaddes, G. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0456-2 · Cited by 34
Over expression of resistin in adipose tissue of the obese induces insulin resistance
Sadashiv (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i7.135 · Cited by 34
Liao, Y., Sung, Y.-C., Chou, C., & Chen, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160167 · Cited by 34
ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia
Chan, D. C., Pang, J., Barrett, P. H. R., SULLIVAN, D. R., Burnett, J. R., BOCKXMEER, F. M. V., & Watts, G. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2217 · Cited by 34
Tagliaferri, V., Romualdi, D., Guido, M., Mancini, A., Cicco, S. D., Florio, C. D., Immediata, V., Segni, C. D., & Lanzone, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0358 · Cited by 34
Bielorai, B., Weintraub, Y., Hutt, D., Hemi, R., Kanety, H., Modan‐Moses, D., Goldstein, G., Hadar, D., Lerner‐Geva, L., Toren, A., et al. (2016) · Clinical Transplantation · doi:10.1111/ctr.12903 · Cited by 34
Effect of Weight Loss on Puberty Onset in Overweight Children
Reinehr, T., Bosse, C., Lass, N., Rothermel, J., Knop, C., & Roth, C. L. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.01.066 · Cited by 34
Hayashi, J., Hasegawa, A., Hayashi, K., Suzuki, T., Ishii, M., Otsuka, H., Yatabe, K., Goto, S., Tatsumi, J., & Shin, K. (2017) · BMC Oral Health · doi:10.1186/s12903-017-0369-2 · Cited by 34
Okura, T., Ueta, E., Nakamura, R., Fujioka, Y., Sumi, K., Matsumoto, K., Shoji, K., Matsuzawa, K., Izawa, S., Nomi, Y., et al. (2017) · Journal of Diabetes Research · doi:10.1155/2017/5139750 · Cited by 34
Associations of sodium intake with obesity, metabolic disorder, and albuminuria according to age
Oh, S. W., Koo, H., Han, K. H., Han, S. Y., & Chin, H. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188770 · Cited by 39
Circulating bone morphogenetic protein-9 in relation to metabolic syndrome and insulin resistance
Xu, X., Li, X., Yang, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17807-y · Cited by 34
Asiatic acid attenuates high-fat diet-induced impaired spermatogenesis
Miao, X., Gao, G., Jiang, L., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5672 · Cited by 34
Metformin in the Management of Childhood Obesity: A Randomized Control Trial
Warnakulasuriya, L. S., Fernando, M. M. A., Adikaram, A. V. N., Thawfeek, A. R. M., Anurasiri, W.-M. L., Silva, R., Sirasa, M. S. F., Rytter, E., Forslund, A. H., Samaranayake, D., et al. (2018) · Childhood Obesity · doi:10.1089/chi.2018.0043 · Cited by 34
Chronic stress, sense of coherence and risk of type 2 diabetes mellitus
Madhu, S. V., Siddiqui, A. A., Desai, N. G., Sharma, S., & Bansal, A. K. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.08.004 · Cited by 34
Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm
Cho, Y., Lim, S., Joo, S. K., Jeong, D., Kim, J. H., Bae, J. M., Park, J. H., Chang, M. S., Lee, D. H., Jung, Y. J., et al. (2019) · Liver International · doi:10.1111/liv.14163 · Cited by 34
Nonalcoholic Fatty Liver and Insulin Resistance Among Petrochemical Workers
Cotrim, H. P., Carvalho, F. M., Siqueira, A. C., et al. (2005) · JAMA · doi:10.1001/jama.294.13.1618-b · Cited by 34
Ronchi, C. L., Arosio, M., Rizzo, E., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02769.x · Cited by 34
l’Allemand, D., Eiholzer, U., Rousson, V., Girard, J., Blum, W. F., Torresani, T., & Gasser, T. (2002) · Hormone Research in Paediatrics · doi:10.1159/000066263 · Cited by 34
Oral, B., Ceyhan, B. M., Dilek, M., Alanoğlu, G., & Sütçü, R. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802549874 · Cited by 34
Wheatcroft, S. B., Kearney, M. T., Shah, A. M., Grieve, D., Williams, I. L., MIELL, J. P., & Crossey, P. A. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2075 · Cited by 34
Impaired Fat‐induced Thermogenesis in Obese Subjects: The NUGENOB Study
Blaak, E. E., Hul, G. B. J., Verdich, C., Štich, V., Martínez, J. A., Petersen, M., Feskens, E. J. M., Patel, K., Oppert, J., Barbe, P., et al. (2007) · Obesity · doi:10.1038/oby.2007.606 · Cited by 34
Recasens, M., López‐Bermejo, A., Ricart, W., Vendrell, J. J., Casamitjana, R., & Fernández‐Real, J. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0708 · Cited by 33
Malmqvist, K. K., Öhman, K. P., Lind, L., Nyström, F. H., & Kahan, T. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200312000-00005 · Cited by 34
LDL particle size, fat distribution and insulin resistance in obese children
Miyashita, M., Okada, T., Kuromori, Y., & Harada, K. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602333 · Cited by 36
Sheu, W. H., Wu, H., Wang, C., et al. (2001) · Internal Medicine · doi:10.2169/internalmedicine.40.584 · Cited by 34
A novel 111/121 diplotype in the Calpain-10 gene is associated with type 2 diabetes
Kang, E. S., Kim, H. J., Nam, M., Nam, C. M., Ahn, C. W., Soo, B., & Lee, H. C. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0410-9 · Cited by 34
Metabolic syndrome and new category ‘pre-hypertension’ in a Japanese population
Kanauchi, M., Kanauchi, K., Hashimoto, T., & Saito, Y. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904x2042 · Cited by 34
The Biological Variation of Insulin Resistance in Polycystic Ovarian Syndrome
Jayagopal, V., Kilpatrick, E. S., Holding, S., Jennings, P. E., & Atkin, S. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8404 · Cited by 33
Davis, J. N., Ventura, E. E., Alexander, K. E., Salguero, L. E., Weigensberg, M. J., Crespo, N. C., Spruijt‐Metz, D., & Goran, M. I. (2007) · International Journal of Pediatric Obesity · doi:10.1080/17477160601133077 · Cited by 34
Arvaniti, V., Thomopoulos, K., Tsamandas, A. C., Makri, M. G., Psyrogiannis, A. I., Vafiadis, G., Assimakopoulos, S. F., Asimakopoulos, S., & Labropoulou-Karatza, C. (2008) · PubMed · Cited by 34
Hyperinsulinemia and Carotid Atherosclerosis in Hypertensive and Control Subjects
Rantala, A. O., Päivänsalo, M. J., Kauma, H., Lilja, M., Savolainen, M. J., Reunanen, A., & Kesäniemi, Y. A. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1188 · Cited by 34
Bahia, L., Kraemer‐Aguiar, L. G., Villela, N. R., Bottino, D. A., Godoy‐Matos, A. F., Geloneze, B., Tambascia, M. A., & Bouskela, E. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.003 · Cited by 33
Florez, J. C., Wiltshire, S., Agapakis, C. M., Burtt, N. P., de Bakker, P. I. W., Almgren, P., Boström, K. B., Tuomi, T., Gaudet, D., Daly, M. J., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0954 · Cited by 34
Yuen, K. C. J., Ong, K. K., Husbands, S., Chatelain, P., Fryklund, L., Gluckman, P. D., Ranke, M. B., Cook, D. M., Rosenfeld, R. G., Wass, J. A. H., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8460 · Cited by 34
A study in the relationships between leptin, insulin, and body fat in Asian subjects
Ho, S., Tai, E., Eng, P., Ramli, A., Tan, C., & Fok, A. C. K. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800801 · Cited by 33
Snehalatha, C., Viswanathan, V., Mohan, R., Satyavani, K., Sivasankari, S., Megha, T., Radhika, S., & Ramachandran, A. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.226 · Cited by 34
Hettihewa, L. M., Palangasinghe, S., Jayasinghe, S. S., Gunasekara, S. W., & Weerarathna, T. P. (2006) · CogPrints (University of Southampton) · Cited by 34
Dye, L., Mansfield, M. W., Lasikiewicz, N., Mahawish, L., Schnell, R., Talbot, D. C. S., Chauhan, H., Croden, F., & Lawton, C. L. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509991504 · Cited by 34
Madjd, A., Taylor, M. A., Delavari, A., Malekzadeh, R., Macdonald, I. A., & Farshchi, H. R. (2021) · British Journal of Nutrition · doi:10.1017/s0007114520004456 · Cited by 34
“Insulin resistance was evaluated by homoeostasis model assessment of insulin resistance (HOMAIR), which was calculated by using the following formula(25):”
Gastric Bypass Surgery Elevates NT-ProBNP Levels
Abrahamsson, N., Engström, B. E., Sundbom, M., & Karlsson, F. A. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0889-z · Cited by 33
Ribeiro, C. B., Ramos, F. M., Manthey, J. A., & Cesar, T. B. (2019) · Phytotherapy Research · doi:10.1002/ptr.6386 · Cited by 33
“Homeostasis Model Assessment (HOMA‐IR) was calculated, and the cutoff set was at ≥2.71 (Matthews et al., 1985).”
MethodInfluentialTharmaraja, T., Stahl, D., Hopkins, C. W. P., Persaud, S. J., Jones, P. M., Ismail, K., & Moulton, C. D. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000707 · Cited by 35
Benhalima, K., Van Crombrugge, P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., De Block, C., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030383 · Cited by 33
“The homeostasis model assessment of insulin resistance (HOMA-IR) and β-cell function (HOMA-B), were measured in early pregnancy, as previously described [17].”
MethodRelationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes
Hong, S.-H., Hong, Y. S., Jeong, K., Chung, H., Lee, H., & Sung, Y.-A. (2020) · Scientific Reports · doi:10.1038/s41598-020-66633-2 · Cited by 32
Palomba, S., Falbo, A., Battista, L., Russo, T., Venturella, R., Tolino, A., Orio, F., & Zullo, F. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.11.042 · Cited by 33
Ji, B., Qu, H., Wang, H., Wei, H., & Deng, H. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0878-5 · Cited by 35
Relationship Between Adipokines, Cognition, and Brain Structures in Old Age Depending on Obesity
Ha, J.-H., Kwak, S., Kim, K. Y., Kim, H., Cho, S. Y., Kim, M., Lee, J., & Kim, E. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac021 · Cited by 33
Kwon, M., Kim, Y., Lee, J., Manthey, J. A., Kim, Y., & Kim, Y. (2022) · Nutrients · doi:10.3390/nu14051087 · Cited by 35
Zhang, S., Liu, X., Wang, J., Yuan, F., & Liu, Y. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00852-7 · Cited by 33
Chen, S., Miki, T., Fukunaga, A., Eguchi, M., Kochi, T., Nanri, A., Kabe, I., & Mizoue, T. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.06.039 · Cited by 36
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
